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Abstract: CD1d presents lipid antigen to a conserved population of natural
killer (NK) T cells, which participate in host immune defense, tumor cell
rejection and suppression of autoimmunity. The levels of human CD1d
expression vary significantly between individuals. To understand such
variation, we sequenced the region up to 1.7 kb 50 upstream of the translation
start site and partially through exon 2 in 44 white Americans. We also studied
two tagged single nucleotide polymorphisms (SNP) in 112 white Americans,
60 African-Americans, 88 Europeans, and 84 Chinese people from the region.
Six SNP present in the region (836C!T, 773C!T, 764C!G,
713A!T, 365A!G and þ363A!G) were found to be in a complete
linkage disequilibrium and comprised three haplotypes. Haplotype 1 had
836C, 773C, 764C, 713A, 365A and þ363A. Haplotype 2 had 836C,
773T, 764C, 713A, 365A and þ363A. Haplotype 3 had 836T, 773C,
764G, 713T, 365G and þ363G. 773C!T and 764C!G can serve as
the tagged SNP to differentiate the three haplotypes. The frequency of
haplotype 1 was significantly higher in African Americans than in the other
three ethnic groups, whereas the frequency of haplotype 3 was significantly
higher in the Chinese people than those in the other three groups. The finding
of the three haplotypes provides a genetic marker for CD1d and facilitates the
study of the functional role of the genetic variations in human CD1d
expression and regulation.
CD1d molecules are cell surface glycoproteins that are non-covalently
associated with b2-microglobulin to form a heterodimeric three-
dimensional structure that is similar to the molecules of class I
major histocompatibility complex (MHC) (1). The gene encoding
CD1d molecule or CD1D gene belongs to group II of the CD1 gene
family in human. Group I CD1 genes include CD1A, CD1B, CD1C and
CD1E based on their sequence homology (2, 3). The CD1 genes are
located in chromosome 1 q22–23 in the human (4, 5). CD1D gene has no
significant sequence homology in the 50 untranslated region with the
group I genes, whereas the latter genes share significant homology in
the region (6). Unlike MHC class I and II genes, the polymorphism in
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the coding region of the CD1 gene family is very limited. Only two
alleles have been described for CD1A, -B, -C, and -D and four alleles
for CD1E (7–9). Among the CD1 molecules, CD1d is highly conserved
across species and is the only group CD1 molecule functionally
present in mice and rats (10–13). Both human and mouse CD1d
can present a-glactosylceramide (a-GlaCer) to natural killer T (NK T)
cells, which express a restricted range of T cell receptors bearing a
single invariant Va-chain (Va14Ja281 in mice and Va24inv in human)
to stimulate specific immune responses (14, 15).
Genetic factors as well as environmental factors play a role in
human CD1d expression and regulation. The expression of CD1d
molecules in mice is constitutive in the bone-marrow-derived cells
including B-lymphocytes, macrophages, and dendritic cells (16–19).
Unlike mouse CD1d molecules, the expression of CD1d in human
does not appear constitutive (1). The levels of CD1d expression varied
among different donors on T lymphocytes (20), monocytes, or
monocyte-derived dendritic cells (21). CD1d expression can be up-
regulated on intestinal epithelial cells and keratinocytes by gamma
interferon (22, 23) or on peripheral blood T cells by mitogen stimula-
tion (20, 24). Patients with psoriasis have an over-expression of CD1d
on keratinocytes (23) and patients with allergic reactions to cow’s
milk have higher levels of CD1d expression in the duodenal lamina
propria than healthy controls (25). In addition, patients with primary
biliary cirrhosis, an autoimmune liver disease, have an increased
expression of CD1d on the epithelial cells of the small bile ducts
(26). It remains to be investigated whether the difference in the CD1d
expression between individuals is due to their genetic variation or an
environmental stimulation or both.
Knowledge of the genetic factors that are involved in CD1d expres-
sion would help in understanding how the gene products function in
NK T cell-associated immune regulation. Multiple SNP in the
upstream region of the human CD1D gene have been noted and listed
in the human genome databank. Such SNP may serve as unique
genetic markers for CD1d or may be used to study their functional
role in CD1d expression and regulation. However, these SNP have not
been validated or systematically studied. To confirm the presence of
the SNP in the upstream region of the CD1D gene and to look for
genetic markers that can be used for a CD1D gene related disease
association study, we sequenced the region 1.7 kb upstream of the
translation start site of the CD1D gene, exon 1, intron 1 and the 50
portion of exon 2 in white Americans. We found that the SNP in the
region are in complete linkage disequilibria and comprise three
haplotypes. Two tagged SNP that can be used to differentiate the
three haplotypes were also tested in white Americans, African
Americans, Europeans and Chinese people. We found that the
distribution of the three haplotypes based on the two tagged SNP
differed significantly among these four ethnic groups.
The subjects were 112 white Americans, 60 African-Americans,
88 Europeans, and 84 Chinese people. The participants were either
healthy volunteers or children being evaluated for non-immune
conditions. Subjects were studied after written informed consents
were obtained.
Genomic DNA samples were prepared from peripheral blood
mononuclear cells, or buccal cells collected using swirl swabs. The
isolation of genomic DNA from the peripheral blood mononuclear
cells was as previously described (27) using proteinase K digestion,
followed by phenol-chloroform extraction. For the isolation of geno-
mic DNA from buccal cells, participants were asked to rinse out their
mouths twice with water. Buccal cells were collected with a sample
collection swab (Epicentre, Madison, WI) by rolling it firmly on the
inside of the cheek approximately 20 times on each side. The cells on
the swab were suspended in phosphate buffered saline (PBS), pH 7.4.
After the pellet was washed once with PBS, the pellet was suspended
in a proteinase K digestion buffer containing 10 mM Tris (pH 7.8),
5 mM ethylenediaminetetraacetic acid (EDTA), and 0.5% sodium
dodecyl sulfate. Proteinase K (Sigma, St. Louis, MO) at a final con-
centration of 30mg/mL was added to the solution and incubated at
55C overnight. The DNA was extracted twice with phenol chloro-
form. DNA was precipitated with 2-isopropanol, and the pellet was
washed twice with 70% ethanol. The isolated DNA was diluted in
Tris-EDTA buffer and stored at 20C.
Genomic DNA located between 1738 and þ508 of the human
CD1D gene was amplified using PCR. The primers used in the
amplification were 50CTA GAG TGT GGT GCA GTA GC30 and
50CTC TCT GAA GCC TTG GTC C30. The PCR amplifications
were performed on 50 ng genomic DNA in a 25mL volume containing
1 unit Platinum Pfx DNA polymerase (Invitrogen, Carlsbad, CA)
using the buffer provided and the addition of 8% dimethyl sulfoxide
(Sigma). The PCR reactions were subjected to a 35-cycle reaction at
60C annealing temperature using an automated thermal cycler
(9700, PE Applied Biosystems, Foster City, CA). The PCR products
were separated in agarose gel and the band corresponding to the
expected size was removed. The DNA was isolated using a kit
(Qiagen, Valencia, CA) following the manufacturer’s instructions.
The isolated PCR products were processed for direct sequencing.
For TA cloning, the PCR products were reacted with 1 unit of Taq
polymerase at 72C for 10 min to add a single deoxyadenosine to the
30 ends, then processed for TA cloning (Invitrogen) as per the manu-
facturer’s instructions. Plasmid DNA was isolated using a com-
mercial kit (Promega, Madison WI) and processed for sequencing.
Approximately 10 ng of the PCR product or 300 ng of the plasmid
DNA was sequenced using the ABI PRISM 377 DNA Sequencer (PE
Applied Biosystems). The primers used in the sequencing reaction
were M13-F, M13-R, provided by the manufacturer (Invitrogen), and
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the gene specific primers including 50CTA GAG TGT GGT GCA
GTA GC30; 50CTC TCT GAA GCC TTG GTC C30; 50AGT GAG GGA
GAG GGA GGT G30; 50AAG AGT GCG CAG GTC AGA G30 and
50AAC CTA CTG AAG TGA GCG GC30.
A double restriction enzyme digestion was used to screen for
haplotype. A PCR product was generated using a primer pair, 50-
AGT GAG GGA GAG GGA GGT G30 and 50GCC GCT CAC TTC
AGT AGG TT30 to cover the region of 1009 to 240 upstream of
CD1D gene. The PCR condition was same as that described above.
The PCR product (10mL) was digested with the restriction enzyme
NgoM IV or Avr II (New England Biolabs, Beverly, MA) using the
conditions recommended by the manufacturer and separated in a
2.5% agarose gel and visualized under UV.
For the calculation of allelic or haplotype frequencies, subjects
with heterozygous alleles or haplotypes were counted for the pre-
sence of each allele or haplotype of interest, while subjects with
homozygous alleles or haplotypes were counted twice. The numbers
of a specific alleles or haplotypes were then divided by the total
numbers of alleles or haplotypes in the group and multiplied by
100 to express the frequencies as percentages. Chi-square tests with
Yates’ correction were used and P-values of less than 0.05 were
considered to be statistically significant.
Genomic DNA samples from 44 white Americans were amplified
between 1738 and þ508 of the CD1D gene and sequenced using
multiple primer pairs in the region. The sequence data were manually
reviewed, then analyzed using Sequencher 4.1 software (Gene Codes
Corporation, Ann Arbor, MI). Six SNP were detected in this region
(Table 1). The nomenclature for the identified SNP was based on a
recent recommendation, in which the nucleotide þ1 is the A of the
ATG-translation initiation codon and the nucleotide 50- to þ1 is
numbered 1 (28). The sequence of the published cDNA (2) and a
genomic DNA sequence obtained from the GenBank (Accession No.
AL138899) were used as the reference to analyze the detected SNP.
We found that five of the six SNP were located 50 upstream of the
CD1D coding region (836C!T, 773C!T, 764C!G,
713A!T, 365A!G) and one was within intron 1 (þ363A!G)
of the CD1D gene (Table 1). We did not find any other SNP or
mutations in the region. The reported SNP þ482A!T in the exon
2 (7) was not found in our samples. þ482A was present in all 44
samples sequenced.
The SNP were analyzed for the presence of haplotypes in the
region. Six SNP combinations were present in the 44 individuals
tested (Table 1). The combination in the individuals with the homo-
zygous alleles for the six SNP indicates the presence of three haplo-
types as seen in the SNP combination 1–3 or referred to as haplotype
1–3 in Table 1. Haplotype 1 and haplotype 2 differ only in SNP
773C!T. The former is 773C, and the latter is 773T. However,
haplotype 3 has diverse SNP compared to haplotype 1 and 2. Haplo-
type 1 and haplotype 3 differ in 836C!T, 764C!G, 713A!T,
365A!G, and þ363A!G. Haplotype 2 and haplotype 3 differ in
all of the six detected SNP. In addition, genomic DNA sequenced data
derived from two African-Americans, four Hispanic-Americans, two
Chinese and one Indian showed the six SNP and gave the same
pattern of the three haplotypes (data not shown).
To confirm the presence of the three haplotypes, PCR products
covering the region between 1738 and þ508 of CD1D gene from 20
additional individuals were cloned into a TA cloning vector and
sequenced. The sequences from each of the individuals were aligned
for SNP presentation and haplotype formation. We found that all six
SNP were present in each of the three haplotypes in individuals with
either the heterozygous or homozygous haplotype as described above
(data not shown).
The identified SNP were compared with the SNP in the region
available in the DNA database of the National Center for Biotechno-
logy Information (NCBI). There are eight listed SNP in the region.
These eight SNP were detected primarily by looking at overlaps
between clones that cover the same region of the genome and vali-
dated either by multiple, independent submissions to the ref SNP
cluster, or by frequency or genotype data according to NCBI. Most of
these SNP lack validation information, and all of them do not have
SNP and haplotypes in 44 white Americans
SNP
combination
836C!T 773C!T 764C!G 713A!T 365A!G þ363A!G n (%)
1 C C C A A A 10 (23)
2 C T C A A A 5 (11)
3 T C G T G G 1 (2)
4 C C/T C A A A 12 (27)
5 C/T C C/G A/T A/G A/G 10 (23)
6 C/T T/C C/G A/T A/G A/G 6 (14)
Table 1
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the information on allelic frequency according to NCBI and PubMed
line searches. All of the six SNP identified in our study were among
the eight SNP. These six SNP were rs859008 (836C!T),
rs3754471(773C!T), rs859009 (764A!T), rs85910 (713A!T),
rs859011 (365A!G) and rs859013 (þ363A!G). Two of the listed
SNP in the region, rs859007 (1340G!A) and rs859012 (45G!A)
are not present in our data set. Our data were 1340A and 45G.
We then examined whether the three haplotypes were in concor-
dance with the sequences available in the Genebank database. We
identified three separate genomic DNA sequences (Genebank Acces-
sion Nos. AL138899.23, X14974.1 and AB045357.1), which covered
the entire region that had been sequenced. Interestingly, these three
genomic DNA sequences represented each of the three identified
haplotypes. The sequence of AL138899.23 had the SNP of haplotype
1. X14974.1 had the SNP of haplotype 2 and AB045357.1 had the SNP
of haplotype 3. For the two listed SNP that were not showed to be
polymorphic in our data, AL138899.23 had 1340G (rs859007) and
45G (rs859012). AB045357.1 had 1340A and 45A. X14974.1 had
1340A and 45G. Accordingly, at least three haplotypes may be
present upstream of the CD1D coding region.
We developed a double restriction enzyme digestion strategy to
screen a large number of samples for the three haplotypes. The
strategy was based on the finding that the SNP were in complete
linkage disequlibria. Haplotypes 1 and 3 had the SNP 773C,
whereas haplotype 2 had 773T; haplotypes 1 and 2 had 764C,
whereas haplotype 3 had 764G. The detection of these two SNP
with restriction endonuclease digestion of PCR amplicons could
identify each of the three haplotypes (Fig. 1). The results derived
from the double restriction enzyme digestion were in concordance
with those derived from the direct sequence of the genomic DNA
(data not shown). It was thus possible to assign individuals to each of
the three haplotypes based upon this simplified method of restriction
enzyme digestion.
The DNA samples derived from the 112 white Americans, 60
African-Americans, 88 Europeans and 84 Chinese were tested for
the two tagged SNP and analyzed for their allelic frequencies and
haplotype distributions (Fig. 2). The African-Americans had a sig-
nificantly higher frequency for SNP-773C than the white Americans
(77.5% (93/120) vs 63.5% (140/224), 2¼ 8.04, P¼ 0.0046), than the
Europeans (77.5% (93/120) vs 61.4% (108/176), 2¼ 8.52, P ¼
0.0035), and the Chinese (77.5% (93/120) vs 66.7% (112/168),
2¼ 4.00, P¼ 0.0454). There was no significant difference in the
frequency for the SNP-773C between white Americans and
Europeans or Chinese. However, the frequency of SNP 764G was
significantly higher in Chinese than in white Americans (42.3%
(71/168) vs 16.5% (37/224), 2¼ 31.88, P< 0.0001), Europeans
(42.3% (71/168) vs 10.8% (19/176), 2¼ 44.06, P< 0.0001], or African-
Americans (42.3% (71/168) vs 8.3% (10/110), 2¼ 39.86, P< 0.0001).
There was no significant difference in the allelic frequency for SNP
764C or 764G among the white Americans, Europeans or Chinese
after Yates corrections.
The haplotypes comprised by the two-tagged SNP were also
analyzed based on the method illustrated in Fig. 1. The distribution
of the haplotypes comprised by the two-tagged SNP differed signifi-
cantly between the four ethnic groups (Table 2). The frequency of the
homozygous haplotype of 773C/764C (haplotype-1/1) was signifi-
cantly higher in the African-Americans than that in the other three
ethnic groups (P< 0.001). The frequency of the homozygous haplo-
type of 773T/764C (haplotype-2/2) was significantly higher in the
white Americans than in the African-Americans or the Europeans
(P< 0.05). However, the frequency of the homozygous haplotype of
773C/764G (haplotype-3/3) was significantly higher in the Chi-
nese than in the white Americans or the Europeans (P< 0.0001),
indicating that haplotype 3 was predominantly present in the
Chinese. This was also supported by the data, which were analyzed
for the distribution of the three individual haplotypes (Fig. 2). The fre-
quency of the heterozygous haplotype of 773CT/764C (haplotype-
1/2) was significantly higher in the Europeans than those derived
from the three other ethnic groups (P< 0.01). The Chinese had the
lowest frequency for this haplotype. However, the frequency of the
heterozygous haplotype of 773CT/764CG (haplotype-2/3) was
significantly higher in the Chinese than those derived from the
three other ethnic groups (P< 0.01).
We found that five SNP in the 1.7 kb upstream of CD1D coding
region and one SNP in intron 1 of the gene were in complete linkage
Fig. 1. Identification of three haplotypes using a double restriction enzyme
digestion method. Top panel: PCR product (1009 to 240) was digested
with Avr II to reveal homozygous 764C (band 246 bp and 524 bp),
homozygous 764G (770 bp) or heterozygous 764C/G. Bottom panel: The
same PCR product was digested with NgoM IV to reveal homozygous 773C
(236 bp and 534 bp), homozygous 773T (770 bp) or heterozygous 773C/T.
The combination of the two revealed the presence of haplotypes for each
individual tested.
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disequilibrium and comprised three haplotypes. We identified two
tagged SNP, 773C!T and 764C!G, which could be typed using
a method of restriction enzyme digestion to differentiate the three
haplotypes. These two tagged SNP were commonly present in the
white Americans, African-Americans, Europeans and Chinese, sug-
gesting that the three haplotypes were also commonly present in
these ethnic groups. However, application of the two tagged SNP to
differentiate the three haplotypes in non-white Americans may be
limited as the two tagged SNP were based on the sequence data
primarily derived from the White Americans.
The three haplotypes could serve as genetic markers for CD1D.
The polymorphism in the coding region of the human CD1D gene
was very limited. Only two alleles (þ482A and þ482T) in exon 2 of
the gene had been reported, although the allelic frequency forþ482T
was only 1% (7).þ482T was not found in our study or in two other
studies (29, 30). It would be interesting to learn the types of SNP in 50
upstream of the coding region in the individuals who had þ482T.
The SNP in the coding region of CD1 genes have been used to
establish an association between CD1 genes and Mycobacterium
malmoense pulmonary disease, although negative results were
reported (28). The use of the rare alleles of the CD1 genes certainly
limits the statistical power in the association studies. It remains to be
established for a linkage disequlibrium between the SNP in the 50
upstream of the coding region and the SNP in the coding region of the
CD1 genes. However, the common polymorphism and the haplotypes
in the 50 upstream of the coding region of the genes should be the
candidate genetic markers for the genes, as polymorphism as well as
haplotypes in the 50 upstream region have been successfully used in
Fig. 2. Distribution of the three haplotypes comprised by the two tagged SNP (773C!G 764C!G) in 112 white Americans (CA), 60 African-Americans
(AA), 88 Europeans (EU), and 84 Chinese (CHI). The frequency of haplotype 1 is significantly higher in the AA than that in the CA (2¼ 16.91, P< 0.0001), that
in the EU (2¼ 10.14, P¼ 0.0015) or in the CHI (2¼ 57.21, P< 0.0001). The frequency of haplotype 1 in CA or EU was also significantly higher than that in the
CHI (2¼ 25.03, P< 0.0001; 2¼ 19.23, P< 0.0001, respectively). However, the frequency of haplotype 2 was significantly lower in the AA than that in the CA
(2¼ 8.04, P< 0.0046), than in the EU (2¼ 8.52, P¼ 0035), or the CHI (2¼ 4.00, P¼ 0.0454). The frequency of haplotype 3 is significantly higher in the CHI
than in the CA (2¼ 31.88, P< 0.0001), than in the AA (2¼ 39.86, P< 0.0001), or the EU (2¼ 44.06, P< 0.0001).









773C/764C (Hap1/1)* 25 (22.3) 30 (50.0) 16 (18.2) 6 (7.2)
773T/764C (Hap2/2)** 20 (17.9) 4 (6.7) 7(8.0) 12 (14.3)
773C/764G (Hap3/3)*** 6 (5.4) 0 (0.0) 1 (1,1) 18 (21.4)
773C/T/764C (Hap1/2)† 36 (32.1) 16 (26.7) 47 (53.4) 13 (15.5)
773C/764C/G (Hap1/3) 17 (15.2) 7 (11.7) 10 (11.4) 16(19.0)
773C/T/764C/G (Hap2/3)†† 8 (7.1) 3 (5.0) 7(8.0) 19 (22.6)
CA, white Americans; AA, African-Americans; EU, Europeans; CHI, Chinese
*AA vs CA: 2 ¼13.76, P¼0.0002. AA vs EU: 2 ¼16.86, P<0.00001. AA vs CHI: 2 ¼34.29, P<0.00001. CA vs CHI: 2 ¼8.31, P¼0.0040. EU vs CHI: 2 ¼4.69, P¼0.0303
**CA vs AA, 2 ¼4.07, P¼0.0435. CA vs EU: 2 ¼4.14, P¼0.0419
***CHI vs CA: 2 ¼11.54, P¼0.007. CHI vs AA, 2 ¼14.69, P¼0.0001. CHI vs EU: 2 ¼18.01, P<0.00001
†EU vs CA: 2 ¼9.18, P¼0.0024. EU vs AA: 2 ¼10.44, P¼0.0012. EU vs CHI: 2 ¼27.22, P<0.00001. CA vs CHI: 2 ¼7.11, P¼0.0077
††CHI vs CA: 2 ¼9.68, P¼0.0019. CHI vs AA: 2 ¼8.39, P¼0.0038. CHI vs EU: 2 ¼7.2, P¼0.0073
Table 2
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disease association studies (31). If the three haplotypes had functional
effects on CD1d expression or regulation, the haplotypes could serve
as functional markers for CD1d molecules as well as the genetic
markers for the locus. Our unpublished observation suggests that
the region between 985 and þ24, which contains the above five
SNP, has promoter activity. In addition, presence of the nucleotide
‘-836C’ in the SNP 836C!T introduces two putative cis-regulatory
elements (TCF-1 and gamma-IRE_CS), and the presence of ‘-836T’ in
the position removes both of the elements based on the program of
SIGSCAN (32).
It would be interesting to learn whether the three identified haplo-
types could be associated with a disease condition. Like MHC class I
molecules, CD1d molecules are involved in the antigen presentation
and immune regulation. In contrast to the MHC class I molecules, the
ligand-binding groove of the CD1d is hydrophobic with a narrower
and deeper shape (33). The polymorphism in the coding region of the
MHC class I genes is much higher than that of CD1D gene. This may
lead to the fact that class I molecules have diverse ligand peptides for
antigen presentation whereas CD1d has only one known lipid anti-
gen, a-GlaCer. Accordingly, the effects of the individual genetic
variation on CD1D may be associated with levels of the gene expres-
sion, CD1d tissue distribution and the response of the gene to environ-
mental stimulation, rather than with the ligand diversity in the
antigen presentation. The reported individual variations in the levels
of CD1d expression (20, 21) are possibly due to a genetic variation
associated with the transcriptional regulation of the gene. It invites
investigation whether the three haplotypes are associated with those
diseases that have an abnormal NK T cell function as an abnormal
CD1d expression in the thymus or periphery may lead to an abnor-
mal functional development of the CD1d restricted NK T cells.
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